206 related articles for article (PubMed ID: 5347178)
21. [For a better control of placental tumors].
Amiel JL; Roger M
Nouv Presse Med; 1976 Mar; 5(13):856-61. PubMed ID: 1264627
[No Abstract] [Full Text] [Related]
22. [Value of chorionic gonadotropin determination, using a serologic technic, in follow-up studies of mola hydatosa].
Wawryk R; Samochowiec E; Dudkiewicz J
Ginekol Pol; 1973 Dec; 44(12):1413-8. PubMed ID: 4587837
[No Abstract] [Full Text] [Related]
23. [Role of hydatidiform mole in the pathogenesis of choriocarcinoma].
Semenovskiĭ AV; Garmanova NV
Vopr Onkol; 1987; 33(7):43-7. PubMed ID: 3617611
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha-fetoprotein in hydatidiform mole, choriocarcinoma, and twin pregnancy.
Ishiguro T
Am J Obstet Gynecol; 1975 Feb; 121(4):539-41. PubMed ID: 1146880
[TBL] [Abstract][Full Text] [Related]
25. The follow-up of hydatidiform mole with quantitative immunological gonadotrophin assays.
Teoh ES
J Obstet Gynaecol Br Commonw; 1967 Dec; 74(6):886-95. PubMed ID: 6071006
[No Abstract] [Full Text] [Related]
26. Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG).
Bagshawe KD; Wilson H; Dublon P; Smith A; Baldwin M; Kardana A
J Obstet Gynaecol Br Commonw; 1973 May; 80(5):461-8. PubMed ID: 4351453
[No Abstract] [Full Text] [Related]
27. Methotrexate for prophylaxis of choriocarcinoma.
Ratnam SS; Teoh ES; Dawood MY
Am J Obstet Gynecol; 1971 Dec; 111(8):1021-7. PubMed ID: 5166997
[No Abstract] [Full Text] [Related]
28. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
Luschin-Ebengreuth G; Petru E; Pickel H
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
[No Abstract] [Full Text] [Related]
29. Difficulties in the management of patients with metastatic choriocarcinoma.
Razis OV; Papadimitriou GC; Dimitriades M; Panopoulos C; Athanassiou A
Int Surg; 1977 Feb; 62(2):88-9. PubMed ID: 300373
[No Abstract] [Full Text] [Related]
30. [Studies on the probable prevention of postmolar choriocarcinoma (author's transl)].
Arai S
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):89-95. PubMed ID: 7061897
[No Abstract] [Full Text] [Related]
31. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
32. CHORIOCARCINOMA IN THE PHILIPPINES.
ACOSTA-SISON H
Philipp J Surg Surg Spec; 1964; 19():27-31. PubMed ID: 14151472
[No Abstract] [Full Text] [Related]
33. CHORIOCARCINOMA AND RELATED TROPHOBLASTIC TUMORS IN WOMEN.
LATHROP JC
N Y State J Med; 1964 Jun; 64():1598-602. PubMed ID: 14154586
[No Abstract] [Full Text] [Related]
34. Lung metastatic choriocarcinoma: chemotherapy and lobectomy.
Wainrach B; Rachima M; Levy MJ
Chest; 1973 Jun; 63(6):1029-30. PubMed ID: 4711850
[No Abstract] [Full Text] [Related]
35. Prophylactic chemotherapy of hydatidiform mole.
Kaku M
Am J Obstet Gynecol; 1966 Jun; 95(4):590-1. PubMed ID: 4287225
[No Abstract] [Full Text] [Related]
36. Five years' experience with the prevention of trophoblastic tumors by the prophylactic use of chemotherapy in patients with molar pregnancy.
Goldstein DP
Clin Obstet Gynecol; 1970 Dec; 13(4):945-61. PubMed ID: 5516580
[No Abstract] [Full Text] [Related]
37. OPTIMUM TIME FOR PERFORMING HYSTERECTOMY IN CASES OF HYDATIDIFORM MOLE.
ACOSTA-SISON H
Obstet Gynecol; 1964 Jun; 23():851-3. PubMed ID: 14168245
[No Abstract] [Full Text] [Related]
38. TREATMENT OF HYDATIDIFORM MOLE.
CHUN D; BRAGA C; CHOW C; LOK L
J Obstet Gynaecol Br Commonw; 1964 Apr; 71():185-91. PubMed ID: 14140128
[No Abstract] [Full Text] [Related]
39. [CHORIOCARCINOMA. DIAGNOSIS AND TREATMENT].
FUENTESAGUILAR R; RUZMORENO JA
Rev Sanid Milit; 1964; 18():37-51. PubMed ID: 14126548
[No Abstract] [Full Text] [Related]
40. Invasive mole.
Lurain JR; Brewer JI
Semin Oncol; 1982 Jun; 9(2):174-80. PubMed ID: 6289460
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
